{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:57:45Z","timestamp":1781636265931,"version":"3.54.5"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"vor","delay-in-days":6,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002352","name":"Ain Shams University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002352","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Lupus nephritis (LN) remains a major cause of morbidity in childhood-onset systemic lupus erythematosus (SLE). Reliable non-invasive biomarkers for early diagnosis and disease monitoring are still limited. Activated leukocyte cell adhesion molecule (ALCAM) has emerged as a potential urinary biomarker reflecting renal immune injury. This study evaluated the diagnostic and monitoring performance of urinary ALCAM in juvenile LN and its correlation with disease activity scores, renal parameters, histopathological classes and indices.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A controlled cross-sectional and prospective cohort study was conducted on 90 participants. Urinary ALCAM was measured in 60 pediatric patients with SLE, classified into 30 active LN and 30 active SLE non-LN patients, along with 30 age- and sex-matched healthy controls. Follow-up samples were obtained after 3 months of treatment in the active LN group. Associations with disease activity scores (SLEDAI and renal SLEDAI), renal function tests, histopathological classes, and renal pathology activity and chronicity indices were assessed. Diagnostic and monitoring performances of urinary ALCAM were analyzed using ROC curves.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Baseline urinary ALCAM levels were markedly higher in active LN (1001.6 [766.4\u20131186] ng\/mg) compared with active SLE non-LN (229.7 [182\u2013270.5] ng\/mg) and controls (38.75 [25\u201354.5] ng\/mg), with a\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001. Levels declined significantly after treatment to 163.65 [85.6\u2013238.2] ng\/mg, with a\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001. Urinary ALCAM correlated positively with serum creatinine, blood urea, proteinuria, SLEDAI, and renal SLEDAI scores, while negatively with estimated glomerular filtration rate. ROC analysis showed excellent diagnostic performance of urinary ALCAM. A cut-off of &gt;\u2009114.6 ng\/mg (AUC\u2009=\u20090.994, sensitivity of 93.33% and specificity of 100%) differentiated juvenile SLE patients from healthy controls. A cut-off of &gt;\u2009538.7 ng\/mg (AUC\u2009=\u20090.993, sensitivity and specificity of 96.67%) distinguished patients with LN from SLE non-LN. The optimal cut-off for differentiating active LN from remission was\n                      <jats:bold>\u2264<\/jats:bold>\n                      \u2009407 ng\/mg\n                      <jats:bold>(<\/jats:bold>\n                      AUC\u2009=\u20090.989, sensitivity of 86.67%, and specificity of 100%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Urinary ALCAM is a reliable, sensitive and non-invasive biomarker that accurately reflects renal activity and treatment response in juvenile LN. Its strong correlations with disease activity scores and renal functions, along with high diagnostic precision across clinically relevant cut-offs, underscore its potential as a practical tool for early detection, longitudinal monitoring of renal involvement, and guiding treatment decisions particularly when renal biopsy is not feasible and also, reducing reliance on serial biopsies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12969-026-01193-9","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T15:54:49Z","timestamp":1771948489000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Urinary ALCAM signatures define renal activity and therapeutic response in juvenile lupus nephritis"],"prefix":"10.1186","volume":"24","author":[{"given":"Dina Ebrahim","family":"Sallam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"ElGanzoury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar Osama","family":"Abdelnaby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Mohamed","family":"Bakr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally Gouda","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,24]]},"reference":[{"issue":"3","key":"1193_CR1","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s11926-021-00985-0","volume":"23","author":"A Charras","year":"2021","unstructured":"Charras A, Smith E, Hedrich CM. Systemic lupus erythematosus in children and young people. Curr Rheumatol Rep. 2021;23(3):20.","journal-title":"Curr Rheumatol Rep"},{"key":"1193_CR2","doi-asserted-by":"crossref","unstructured":"Davidson A. What is damaging the kidney in lupus nephritis? Nat Rev Rheumatol. 2016 Mar;12(3):143\u201353.","DOI":"10.1038\/nrrheum.2015.159"},{"issue":"1","key":"1193_CR3","doi-asserted-by":"publisher","first-page":"i71","DOI":"10.1093\/ndt\/gfw300","volume":"32","author":"DJ Birmingham","year":"2017","unstructured":"Birmingham DJ, Merchant M, Waikar SS, Nagaraja H, Klein JB, Rovin BH. Biomarkers of lupus nephritis histology and flare: Deciphering the relevant amidst the noise. Nephrol Dial Transpl. 2017;32(1):i71\u20139.","journal-title":"Nephrol Dial Transpl"},{"issue":"9","key":"1193_CR4","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1093\/rheumatology\/kez528","volume":"59","author":"I Parodis","year":"2020","unstructured":"Parodis I, Gokaraju S, Sicker A, Vanarsa K, Zhang T, Habazi D, et al. ALCAM and VCAM-1 as urine biomarkers of activity and long-term renal outcome in systemic lupus erythematosus. Rheumatology (Oxford). 2020;59(9):2237\u201349. Sep1;.","journal-title":"Rheumatology (Oxford)"},{"key":"1193_CR5","doi-asserted-by":"crossref","unstructured":"Vrabie A, Obri\u0219c\u0103 B, Sorohan BM, Ismail G. Biomarkers in lupus nephritis: an evidence-based comprehensive review. Life (Basel). 2025 Sep 23;15(10):1497.","DOI":"10.3390\/life15101497"},{"issue":"2","key":"1193_CR6","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s10555-005-1573-0","volume":"24","author":"GW Swart","year":"2005","unstructured":"Swart GW, Lunter PC, Kilsdonk JW, Kempen LC. Activated leukocyte cell adhesion molecule (ALCAM\/CD166): signaling at the divide of melanoma cell clustering and cell migration? Cancer Metastasis Rev. 2005;24(2):223\u201336.","journal-title":"Cancer Metastasis Rev"},{"key":"1193_CR7","doi-asserted-by":"crossref","unstructured":"Bech-Serra JJ, Santiago-Josefat B, Esselens C, Saftig P, Baselga J, Arribas J, et al. Proteomic identification of desmoglein 2 and activated leukocyte cell adhesion molecule as substrates of ADAM17 and ADAM10 by difference gel electrophoresis. Mol Cell Biol. 2006 Jul;26(13):5086\u201395.","DOI":"10.1128\/MCB.02380-05"},{"issue":"2","key":"1193_CR8","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/ni1551","volume":"9","author":"R Cayrol","year":"2008","unstructured":"Cayrol R, Wosik K, Berard JL, Dodelet-Devillers A, Ifergan I, Kebir H, et al. Activated leukocyte cell adhesion molecule promotes leukocyte trafficking into the central nervous system. Nat Immunol. 2008;9(2):137\u201345.","journal-title":"Nat Immunol"},{"issue":"5","key":"1193_CR9","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1203\/PDR.0b013e31819e4305","volume":"65","author":"M Suzuki","year":"2009","unstructured":"Suzuki M, Wiers K, Brooks EB, Greis KD, Haines K, Klein-Gitelman MS, et al. Initial validation of a novel protein biomarker panel for active pediatric lupus nephritis. Pediatr Res. 2009;65(5):530\u20136.","journal-title":"Pediatr Res"},{"issue":"2","key":"1193_CR10","first-page":"288","volume":"29","author":"DD Gladman","year":"2002","unstructured":"Gladman DD, Iba\u00f1ez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol. 2002;29(2):288\u201391.","journal-title":"J Rheumatol"},{"issue":"9","key":"1193_CR11","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1093\/ckj\/sfad055","volume":"16","author":"JE Rojas-Rivera","year":"2023","unstructured":"Rojas-Rivera JE, Garc\u00eda-Carro C, \u00c1vila AI, Espino M, Espinosa M, Fern\u00e1ndez-Ju\u00e1rez G, et al. Diagnosis and treatment of lupus nephritis: a summary of the consensus document of the Spanish group for the study of glomerular diseases (GLOSEN). Clin Kidney J. 2023;16(9):1384\u2013402.","journal-title":"Clin Kidney J"},{"key":"1193_CR12","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC. Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40:1725.","journal-title":"Arthritis Rheum"},{"issue":"8","key":"1193_CR13","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1002\/art.34473","volume":"64","author":"M Petri","year":"2012","unstructured":"Petri M, Orbai AM, Alarc\u00f3n GS, Gordon C, Merrill JT, Fortin PR, et al. Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012;64(8):2677\u201386.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"1193_CR14","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s13075-020-02209-9","volume":"22","author":"H Ding","year":"2020","unstructured":"Ding H, Lin C, Cai J, Guo Q, Dai M, Mohan C, et al. Urinary activated leukocyte cell adhesion molecule as a novel biomarker of lupus nephritis histology. Arthritis Res Ther. 2020;22(1):100.","journal-title":"Arthritis Res Ther"},{"key":"1193_CR15","doi-asserted-by":"crossref","unstructured":"Weening JJ, D\u2019Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am SocNephrol. 2004 Feb;15(2):241\u201350.","DOI":"10.1097\/01.ASN.0000108969.21691.5D"},{"key":"1193_CR16","doi-asserted-by":"publisher","first-page":"1369385","DOI":"10.3389\/fimmu.2024.1369385","volume":"15","author":"JW Kim","year":"2024","unstructured":"Kim JW, Baek WY, Jung JY, Kim HA, Lee SW, Suh CH. Longitudinal assessment of urinary ALCAM, HPX, and PRDX6 in Korean patients with systemic lupus erythematosus: implications for disease activity monitoring and treatment response. Front Immunol. 2024;15:1369385.","journal-title":"Front Immunol"},{"issue":"4","key":"1193_CR17","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.4049\/jimmunol.173.4.2262","volume":"173","author":"I Gimferrer","year":"2004","unstructured":"Gimferrer I, Calvo M, Mittelbrunn M, Farn\u00f3s M, Sarrias MR, Enrich C, et al. Relevance of CD6-mediated interactions in T-cell activation and proliferation. J Immunol. 2004;173(4):2262\u201370.","journal-title":"J Immunol"},{"issue":"3","key":"1193_CR18","first-page":"E524","volume":"114","author":"MA L\u00e9cuyer","year":"2017","unstructured":"L\u00e9cuyer MA, Saint-Laurent O, Bourbonni\u00e8re L, Larouche S, Larochelle C, Michel L, et al. Dual role of ALCAM in neuroinflammation and blood\u2013brain barrier homeostasis. Proc Natl Acad Sci U S A. 2017;114(3):E524\u201333.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1193_CR19","doi-asserted-by":"publisher","first-page":"369","DOI":"10.4049\/jimmunol.1201864","volume":"191","author":"R von Bauer","year":"2013","unstructured":"von Bauer R, Oikonomou D, Sulaj A, Mohammed S, Hotz-Wagenblatt A, Gr\u00f6ne HJ, et al. CD166\/ALCAM mediates Proinflammatory effects of S100B in delayed-type hypersensitivity. J Immunol. 2013;191(1):369\u201377.","journal-title":"J Immunol"},{"key":"1193_CR20","doi-asserted-by":"crossref","unstructured":"Soliman SA, Haque A, Vanarsa K, Zhang T, Ismail F, Lee KH, et al. Urine ALCAM, PF4 and VCAM-1 surpass conventional metrics in identifying nephritis disease activity in Childhood-Onset systemic lupus erythematosus. Front Immunol. 2022 May;26:13885307.","DOI":"10.3389\/fimmu.2022.885307"},{"issue":"3","key":"1193_CR21","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1007\/s10067-024-06883-x","volume":"43","author":"AS Amer","year":"2024","unstructured":"Amer AS, Abdel Moneam SM, Hashaad NI, Yousef EM, Abd El-Hassib DM. Clinico-serological associations of urinary activated leukocyte cell adhesion molecule in systemic lupus erythematosus and lupus nephritis. Clin Rheumatol. 2024;43(3):1015\u201321.","journal-title":"Clin Rheumatol"},{"issue":"12","key":"1193_CR22","doi-asserted-by":"publisher","first-page":"e138345","DOI":"10.1172\/jci.insight.138345","volume":"5","author":"A Fava","year":"2020","unstructured":"Fava A, Buyon JP, Mohan C, Zhang T, Belmont HM, Izmirly P, et al. Integrated urine proteomics and renal single-cell genomics identify an IFN-\u03b3 response gradient in lupus nephritis. JCI Insight. 2020;5(12):e138345.","journal-title":"JCI Insight"},{"key":"1193_CR23","unstructured":"Fava A, Lee CY, Guthridge C, Nikolopoulos D, Lindblom J, Tamirou F et al. Association of urinary biomarkers with histological features in diagnostic and per-protocol repeat kidney biopsies in lupus nephritis. ACR Convergence. 2025; 2025 Nov; USA. ACR Meeting Abstracts. 2025."}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12969-026-01193-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-026-01193-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-026-01193-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:48:00Z","timestamp":1781635680000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12969-026-01193-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,24]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1193"],"URL":"https:\/\/doi.org\/10.1186\/s12969-026-01193-9","relation":{},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,24]]},"assertion":[{"value":"6 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study gained approval of the Research Ethics Committee of the Department of Pediatrics, Faculty of Medicine, Ain Shams University. Ethical approval number is FMASU MS 307\/2024. The study was conducted in accordance with the Declaration of Helsinki. An informed consent was obtained from the parents or caregivers of each participant before enrolment after full explanation of the aim and the needed assessment tools of the study, with their ability to withdraw from the study whenever they want without any consequences.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors consent to publication of this work and affirm that the manuscript is original and has not been submitted elsewhere.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14"}}